Javascript must be enabled to continue!
Cancer, General Principles of Biological Treatments
View through CrossRef
Biological therapy for cancer is a type of treatment that uses the body's immune system to kill cancer cells. Biological therapy for cancer is used in the treatment of many types of cancer to prevent or slow tumor growth and to prevent the spread of cancer. Biological therapy for cancer often causes fewer toxic side effects than do other cancer treatments. The goal of biological therapy for cancer is to induce your immune system to recognize and kill cancer cells. Your body's immune system fights invaders, such as germs, throughout your body. Your immune system should also recognize cancer cells as abnormal, but it doesn't always do that. Cancer cells can develop an ability to hide from immune system cells. Or cancer cells can disable or inhibit immune system cells from acting [1,2].
In general, biological therapies work by:
1. Inducing the immune system to attack cancer cells. There are several ways biological therapy treatments can achieve this goal. As an example, chemicals that stimulate your immune system cells could be injected into your body. Or a sample of your immune system cells could be trained in a lab to attack cancer cells before being reintroduced to your body.
2. Making cancer cells easier for your immune system to recognize. Biological therapy can also target the cancer cells, turning on or off cell signals that help them elude the immune system cells. As an example, drugs called immune checkpoint inhibitors can target specific chemical receptors on cancer cells, blocking the signals the cancer cells send to suppress the immune system.
Mapsci Digital Publisher OPC Pvt. Ltd.
Title: Cancer, General Principles of Biological Treatments
Description:
Biological therapy for cancer is a type of treatment that uses the body's immune system to kill cancer cells.
Biological therapy for cancer is used in the treatment of many types of cancer to prevent or slow tumor growth and to prevent the spread of cancer.
Biological therapy for cancer often causes fewer toxic side effects than do other cancer treatments.
The goal of biological therapy for cancer is to induce your immune system to recognize and kill cancer cells.
Your body's immune system fights invaders, such as germs, throughout your body.
Your immune system should also recognize cancer cells as abnormal, but it doesn't always do that.
Cancer cells can develop an ability to hide from immune system cells.
Or cancer cells can disable or inhibit immune system cells from acting [1,2].
In general, biological therapies work by:
1.
Inducing the immune system to attack cancer cells.
There are several ways biological therapy treatments can achieve this goal.
As an example, chemicals that stimulate your immune system cells could be injected into your body.
Or a sample of your immune system cells could be trained in a lab to attack cancer cells before being reintroduced to your body.
2.
Making cancer cells easier for your immune system to recognize.
Biological therapy can also target the cancer cells, turning on or off cell signals that help them elude the immune system cells.
As an example, drugs called immune checkpoint inhibitors can target specific chemical receptors on cancer cells, blocking the signals the cancer cells send to suppress the immune system.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract
Background: Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. It is the third most common cancer in men in Algeri...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Comprehensive update on cancer scenario of Bangladesh
Comprehensive update on cancer scenario of Bangladesh
AbstractBangladesh, at 142 million people, is the ninth most populous country in the world. There are 13 to 15 lakh cancer patients in Bangladesh, with about two lakh patients newl...
Cardiovascular disease is a significant contributor to the incidence of cancer, second-primary cancer, and cancer-related hospitalization
Cardiovascular disease is a significant contributor to the incidence of cancer, second-primary cancer, and cancer-related hospitalization
Abstract
Introduction
Cardiovascular diseases (CVD) are associated with an increased risk of cancer. However, the populat...

